Valuation: Autobio Diagnostics Co., Ltd.

Capitalization 20.93B 3.02B 2.54B 2.32B 2.21B 4.1B 274B 4.27B 27.02B 10.69B 132B 11.34B 11.11B 472B P/E ratio 2025 *
17.9x
P/E ratio 2026 * 16x
Enterprise value 20.93B 3.02B 2.54B 2.32B 2.21B 4.1B 274B 4.27B 27.02B 10.69B 132B 11.34B 11.11B 472B EV / Sales 2025 *
4.8x
EV / Sales 2026 * 4.36x
Free-Float
29.86%
Yield 2025 *
3.39%
Yield 2026 * 3.76%
More valuation ratios * Estimated data
Dynamic Chart
1 day+0.47%
1 week+1.38%
Current month-0.11%
1 month-1.27%
3 months-5.13%
6 months-10.55%
Current year+3.42%
More quotes
1 week 36.27
Extreme 36.27
36.93
1 month 36.08
Extreme 36.08
39.68
Current year 35.41
Extreme 35.41
39.68
1 year 35.14
Extreme 35.14
45.17
3 years 35.14
Extreme 35.14
71.4
5 years 35.14
Extreme 35.14
104.9
10 years 13.46
Extreme 13.4615
139.22
More quotes
Manager TitleAgeSince
Chief Executive Officer 58 28/10/2018
Director of Finance/CFO 48 12/11/2012
Chief Administrative Officer 50 31/12/2005
Director TitleAgeSince
Director/Board Member 61 31/12/2005
Director/Board Member 59 31/12/2002
Director/Board Member 57 12/11/2012
More insiders
Change 5d. change 1-year change 3-years change Capi.($)
+0.47%+1.38%-10.57%-47.98% 3.02B
+1.18%-2.98%-17.87%-1.02% 13.12B
+3.43%-8.32%+136.88%+270.92% 13.57B
+1.41%-4.33% - - 6.29B
-0.11%+1.73%-13.80%-12.24% 6.13B
+0.29%+0.65%-24.35%-35.74% 4.79B
+0.49%-1.94%-26.49%+10.86% 4.32B
+1.19%+4.39%+1.31%-18.07% 2.58B
-0.38%-7.07%+30.11%-58.01% 2.35B
Average +0.89%-2.59%+9.40%+13.59% 6.24B
Weighted average by Cap. +1.38%-4.12%+27.05%+62.87%
See all sector performances

Financials

2025 *2026 *
Net sales 4.36B 630M 529M 484M 461M 855M 57.14B 889M 5.63B 2.23B 27.46B 2.36B 2.31B 98.29B 4.8B 694M 583M 533M 508M 942M 62.95B 979M 6.2B 2.45B 30.25B 2.6B 2.55B 108B
Net income 1.17B 169M 142M 129M 123M 229M 15.29B 238M 1.51B 596M 7.35B 632M 619M 26.31B 1.31B 189M 159M 145M 139M 257M 17.18B 267M 1.69B 670M 8.26B 710M 696M 29.55B
Net Debt - -
More financial data * Estimated data
Logo Autobio Diagnostics Co., Ltd.
Autobio Diagnostics Co., Ltd. is a China-based company and mainly engaged in development, manufacture and sales of diagnostics products. The Company's main products include gnostic products, microbiology detection products, and related devices. The immunodiagnostic products include microplate chemiluminescence diagnostic reagents, Enzyme-Linked immunosorbent assay diagnostic reagents, magnetic particle chemiluminescence detection reagents, and colloidal diagnostic reagents. The microbiology detection products include training detection reagents, susceptibility detection reagents and rapid detection reagents. The device products include microplate readers, chemiluminescence immunoassay analyzers, and united testing analyzers. The Company distributes its products in domestic markets.
Employees
5,773
More about the company
Date Price Change Volume
09/02/26 36.63 ¥ +0.47% 1,832,968
06/02/26 36.46 ¥ -0.82% 2,282,475
05/02/26 36.76 ¥ +0.22% 2,608,666
04/02/26 36.68 ¥ +0.08% 2,727,776
03/02/26 36.65 ¥ +1.44% 2,537,640

End-of-day quote Shanghai S.E., February 08, 2026

More quotes
Trader
Investor
Global
Quality
ESG MSCI
CCC
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
8
Last Close Price
36.63CNY
Average target price
44.48CNY
Spread / Average Target
+21.44%
Consensus

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Equities
  3. 603658 Stock